Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Vidar Systems Corp. — Predicate Candidate Screening
13 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
76 daysmedian FDA review time
151 days90th percentile
13clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K130636 | TELERADPRO EDGE; TELERADPRO EDGE HD-CCD | Vidar Systems Corp. | 2013-06-07 | 88 | 0 |
| K130406 | DIAGNOSTICPRO EDGE | Vidar Systems Corp. | 2013-04-29 | 69 | 0 |
| K102476 | TELERADPRO | Vidar Systems Corp. | 2010-10-07 | 38 | 0 |
| K093809 | VIDAR DENTAL FILM DIGITIZER | Vidar Systems Corp. | 2010-01-07 | 29 | 0 |
| K071193 | VIDAR VISION 3000 AND 4000 X-RAY SYSTEMS | Vidar Systems Corp. | 2007-05-30 | 30 | 0 |
| K070563 | VIDAR VISION 2000 | Vidar Systems Corp. | 2007-03-16 | 17 | 0 |
| K024171 | VIDAR BONE TRACK SYSTEM SOFTWARE | Vidar Systems Corp. | 2003-03-04 | 76 | 0 |
| K011049 | EXPRESSSUITE | Vidar Systems Corp. | 2001-10-01 | 178 | 0 |
| K993598 | MAMMOGRAPHY PRO, MODEL 13017, DIAGNOSTIC PRO W/ MAMMOGRAPHY | Vidar Systems Corp. | 2000-01-20 | 87 | 0 |
| K993599 | DIAGNOSTIC PRO, MODEL 12772, VXR-16, MODEL 13020, VXR-16 DOS | Vidar Systems Corp. | 2000-01-18 | 85 | 0 |
| K993597 | PLLL, TELERADPRO, MODEL 12714/12715, VXR-12 PLUS, MODEL 8619 | Vidar Systems Corp. | 1999-12-15 | 51 | 0 |
| K974315 | VIDAR VXR LS LASER FILM DIGITIZER | Vidar Systems Corp. | 1998-04-17 | 151 | 0 |
| K933632 | MEDSCAN 12 | Vidar Systems Corp. | 1993-12-13 | 139 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda